Charles Schwab’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$61.1M Sell
4,278,646
-192,952
-4% -$2.76M 0.01% 972
2025
Q1
$47M Sell
4,471,598
-216,012
-5% -$2.27M 0.01% 1112
2024
Q4
$56.8M Buy
4,687,610
+162,994
+4% +$1.97M 0.01% 1040
2024
Q3
$66.5M Sell
4,524,616
-160,443
-3% -$2.36M 0.01% 907
2024
Q2
$67.6M Sell
4,685,059
-23,619
-0.5% -$341K 0.01% 844
2024
Q1
$76.7M Sell
4,708,678
-24,194
-0.5% -$394K 0.02% 748
2023
Q4
$70.5M Buy
4,732,872
+21,692
+0.5% +$323K 0.02% 748
2023
Q3
$53M Buy
4,711,180
+814,668
+21% +$9.16M 0.02% 836
2023
Q2
$39.2M Buy
3,896,512
+418,818
+12% +$4.21M 0.01% 1026
2023
Q1
$32.7M Buy
3,477,694
+83,558
+2% +$785K 0.01% 1125
2022
Q4
$41.5M Buy
3,394,136
+265,128
+8% +$3.24M 0.01% 942
2022
Q3
$38.8M Sell
3,129,008
-62,841
-2% -$780K 0.01% 921
2022
Q2
$62.7M Buy
3,191,849
+230,423
+8% +$4.52M 0.02% 639
2022
Q1
$77.3M Buy
2,961,426
+178,162
+6% +$4.65M 0.02% 626
2021
Q4
$79M Buy
2,783,264
+78,432
+3% +$2.23M 0.02% 640
2021
Q3
$86.3M Buy
2,704,832
+92,110
+4% +$2.94M 0.03% 561
2021
Q2
$90.6M Buy
2,612,722
+37,729
+1% +$1.31M 0.03% 539
2021
Q1
$75.8M Buy
2,574,993
+20,652
+0.8% +$608K 0.03% 599
2020
Q4
$78.3M Buy
2,554,341
+764,894
+43% +$23.5M 0.03% 528
2020
Q3
$50M Buy
1,789,447
+529,513
+42% +$14.8M 0.02% 668
2020
Q2
$27M Buy
1,259,934
+145,039
+13% +$3.11M 0.01% 968
2020
Q1
$25M Buy
1,114,895
+327,065
+42% +$7.32M 0.01% 863
2019
Q4
$23.2M Sell
787,830
-269,669
-26% -$7.94M 0.01% 1104
2019
Q3
$28.1M Sell
1,057,499
-90,678
-8% -$2.41M 0.02% 931
2019
Q2
$38.8M Buy
1,148,177
+21,820
+2% +$738K 0.02% 708
2019
Q1
$36.1M Buy
1,126,357
+1,003,362
+816% +$32.2M 0.02% 730
2018
Q4
$3.88M Buy
+122,995
New +$3.88M ﹤0.01% 2031